Correlation Between Zinwell and Sinphar Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zinwell and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zinwell and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zinwell and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Zinwell and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zinwell with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zinwell and Sinphar Pharmaceutical.

Diversification Opportunities for Zinwell and Sinphar Pharmaceutical

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Zinwell and Sinphar is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Zinwell and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Zinwell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zinwell are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Zinwell i.e., Zinwell and Sinphar Pharmaceutical go up and down completely randomly.

Pair Corralation between Zinwell and Sinphar Pharmaceutical

Assuming the 90 days trading horizon Zinwell is expected to under-perform the Sinphar Pharmaceutical. In addition to that, Zinwell is 1.26 times more volatile than Sinphar Pharmaceutical Co. It trades about -0.08 of its total potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.07 per unit of volatility. If you would invest  3,645  in Sinphar Pharmaceutical Co on September 1, 2024 and sell it today you would lose (560.00) from holding Sinphar Pharmaceutical Co or give up 15.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Zinwell  vs.  Sinphar Pharmaceutical Co

 Performance 
       Timeline  
Zinwell 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zinwell has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Zinwell is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Sinphar Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Zinwell and Sinphar Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zinwell and Sinphar Pharmaceutical

The main advantage of trading using opposite Zinwell and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zinwell position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.
The idea behind Zinwell and Sinphar Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas